期刊文献+

29例新生儿恶臭假单胞菌感染临床特点分析 被引量:1

Clinical characteristics of 29 cases of neonatal pseudomonas putida infection
下载PDF
导出
摘要 目的分析29例新生儿恶臭假单胞菌感染的临床特点,为临床诊治提供参考。方法选取2017年2月至2023年2月湖南省儿童医院新生儿科收治住院的恶臭假单胞菌感染新生儿29例。对其临床资料进行回顾性分析。结果29例新生儿平均胎龄为(33±4)周;足月儿9例,早产儿20例;平均出生体质量为(2187±1053)g,其中极低出生体重儿13例;有广谱抗菌药物用药史,感染前多有长时间静脉营养,12例有机械通气史,11例有消化道疾病手术史,11例经外周静脉穿刺中心静脉置管。临床表现以发热、呼吸困难、反应差、腹胀等为主,出现症状时间为日龄(22±6)d。5例(17.2%)患儿血白细胞计数低,11例(37.9%)血小板计数<100×10^(9)/L,26例(89.7%)C反应蛋白增高,浓度为(64.7±62.5)mg/L,降钙素原增高,浓度为(4.4±4.1)μg/L,白细胞介素-6明显升高9例,其中4例白细胞介素-6>5μg/L,血红蛋白为(101.0±22.8)g/L,球蛋白为(15.6±3.8)g/L,水平偏低。血培养、痰培养、脑脊液培养为鉴定方法,该菌对头孢吡肟、阿米卡星、左氧氟沙星敏感度较高,抗感染治疗后预后大多良好。27例(93.1%)治愈,2例(6.9%)死亡。结论新生儿感染恶臭假单胞菌多以血源性感染为主,早产儿、低出生体重儿、免疫功能低下者易感,有创操作提高感染该菌的风险,抗生素优先选择头孢菌素类、氨基糖苷类、喹诺酮类,选用敏感抗生素治疗预后较好。 Objective To analyze the clinical characteristics of neonatal pseudomonas putida infection in our hospital,and provide reference for clinical diagnosis and treatment.Methods The clinical data of 29 neonatal pseudomonas putida infection treated in the hospital from February 2017 to February 2023 were analyzed retrospectively.Results The average gestational age of 29 neonates was(33±4)weeks,including 9 full-term babies and 20 premature babies;the average birth weight was(2187±1053)g,including 13 very low birth weight infants.All patients were treated with broad-spectrum antibacterial drugs,and were mostly given long-term parenteral nutrition before infection.Twelve patients had mechanical ventilation,11 cases had a surgical history of gastrointestinal disease,and 11 cases had peripheral insertion of central catheters(PICC).The main clinical manifestations were fever,dyspnea,poor response and abdominal distension.Manifestations appeared(22±6)days after birth.Five cases(17.2%)infants were with low white blood cell(WBC)counts,11 cases(37.9%)had thrombocytopenia(<100×10^(9)/L),26 cases(89.7%)had elevated C-reactive protein(CRP),with the average CRP level being(64.7±62.5)mg/L;the average PCT level was increased,being(4.4±4.1)μg/L;interleukin-6(IL-6)was significantly increased in 9 cases,of which interleukin of 4 cases was>5μg/L;hemoglobin level was(101.0±22.8)g/L,and globulin level was(15.6±3.8)g/L,levels being low.Blood culture,sputum culture and bacterial culture of CSF were the identification methods,the bacteria were more sensitive to cefepime,amikacin and levofloxacin,and the prognosis was mostly good after anti-infection treatment.A total of 27 cases(93.1%)were cured and 2 cases(6.9%)died.Conclusion The neonates infected with pseudomonas putida are mainly blood-borne infections,and premature infants,low birth weight infants and immunocompromised infants are susceptible.Invasive operation increases the risk of infection with this bacteria,and cephalosporins,aminoglycosides and quinolones are preferred as antibiotics.Sensitive antibiotics should be selected for treatment,which has a better prognosis.
作者 鲁玉姣 高喜容 庄严 马金霞 李军帅 LU Yujiao;GAO Xirong;ZHUANG Yan;MA Jinxia;LI Junshuai(Department of Neonatology,Hunan Children′s Hospital,Changsha 410007,China)
出处 《中国中西医结合儿科学》 2023年第3期233-236,共4页 Chinese Pediatrics of Integrated Traditional and Western Medicine
基金 湖南省卫生健康委科研计划项目(B2019012) 湖南省科技重大专项(2019SK1014)。
关键词 败血症 恶臭假单胞菌 阿米卡星 新生儿 早产儿 Sepsis Pseudomonas putida Amikacin Neonates Premature infant
  • 相关文献

参考文献2

二级参考文献26

  • 1余鑫之,黄家麟.非铜绿假单胞菌属败血症——附61例报告[J].中华内科杂志,1996,35(5):330-331. 被引量:2
  • 2明德松,庄建良,苏智军,张志珊,谢尊金.泛耐恶臭假单胞菌40种耐药基因的研究[J].世界感染杂志,2007,7(4):273-277. 被引量:8
  • 3Loewen PC, Alsaadi Y, Fernando D, et al. Genome sequence of an extremely drug-resistant clinical isolate of Acinetobacter baumannii strain AB030[-J:. Genome Announc, 2014, 2(5): e01035-14.
  • 4Buhl M, Peter S, Willmann M. Prevalence and risk factors as- sociated with colonization and infection of extensively drug-re- sistant Pseudornonas aeruginosa : a systematic review[J]. Ex- pert Rev Anti Infect Ther, 2015, 13(9): 1159-1170.
  • 5Gurung M, Moon DC, Tamang MD, et al. Emergence of 16S rRNA methylase gene armA and cocarriage of bla(IMP-4) in Pseudomonas aeruginosa isolates from South Korea]-J:. Diagn Microbiol Infect Dis, 2010, 68(4) : 468-470.
  • 6Kitao T, Tada T, Tanaka M, et al. Emergence of a novel mul- tidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallu-13-1actamases and AAC(6')-Iac in Japan[J]. Int J Antimicrob Agents, 2012, 39(6): 518-521.
  • 7Doi Y, de Oliveira Garcia D, Adams J, et al. Coproduction of no- vel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazi[J].Antimicrob Agents Chemother, 2007, 51(3): 852-856.
  • 8Clinical and Laboratory Standards Institute(CLSI). Perform- ance stands for antimicrobial susceptibility testing[S]. M100- S23, 2013.
  • 9Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo β-latamase gene, blaNDM 1, and a novel erythromy- cin esterase gene carried on a unique genetic structure in Kleb- siella pneumoniae sequence type 14 from India[J]. Antimicrob Agents Chemother, 2009, 53(12).- 5046-5054.
  • 10Yang Q, Wang H, Sun H, et al. Phenotypic and genotypie characterization of Enterobacteriaceae with decreased suscepti- bility to carbapenems: results from large hospital-based sur- veillance studies in China[J]. Antimicrob Agents Chemother, 2010, 54(1): 573-577.

共引文献15

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部